Review links omega-3 intake with lower risk of sight-threatening diabetic eye disease
The review reported an eye-disease association in diabetes, but its abstract leaves the reference intake and follow-up unclear.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
In studies involving people with diabetes, omega-3 intake of at least 500 mg/day was associated with lower risk of sight-threatening diabetic retinopathy. The abstract does not identify the reference intake or follow-up for that result. The review's combination of randomized and nonrandomized evidence does not establish a preventive benefit for every patient.
Although randomized and nonrandomized results are reported separately, the abstract does not identify the nonrandomized study designs or explain their contributions to the main estimate.
Markers and eye outcomes
The review also pooled changes in oxidative-stress markers. These laboratory measurements are separate from sight-threatening eye disease; a change in a marker does not itself demonstrate that vision was preserved.
Dietary claims need context
The authors highlight food sources and intake patterns, but the abstract does not show the comparisons behind those claims. This summary cannot establish an optimal intake or preferred food source for preventing eye disease.
The original publication
Association between omega-3 fatty acid intake and risk of diabetic retinopathy: A systematic review and meta-analysis.
Chen KY, Chan HC, Chan CM
J Nutr Health Aging · 2025
- PubMed ID
- 40987202
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.